Skip navigation

Corporate

Our Vision

Surgery Without Complications

Our Mission

Our Mission is to transform surgery through continuous innovation. By leveraging our scientific heritage and proprietary technologies, we will passionately commit ourselves to exceed customer expectations, raise industry standards, and improve patients' lives.

Company Profile

LifeCell develops and markets tissue repair products for use in reconstructive, urogynecologic and orthopedic surgical procedures. LifeCell's current marketed products include: Strattice™ Reconstructive Tissue Matrix and AlloDerm® Regenerative Tissue Matrix, for plastic, reconstructive, general surgical, burn and periodontal procedures; Cymetra® Regenerative Tissue Matrix, a particulate form of AlloDerm® Tissue Matrix suitable for injection; Repliform® Regenerative Tissue Matrix, for urogynecologic surgical procedures; GraftJacket®, for orthopedic surgical procedures; and AlloCraft™ DBM, for bone grafting procedures.  In 2011, LifeCell introduced the SPY Elite® System which helps surgeons to intraoperatively assess tissue perfusion. Most recently, in 2013 LifeCell introduced the REVOLVE™ System to offer fast and efficient high volume fat transfer processing in a range of aesthetic and reconstructive procedures.

 

Before use, physicians should review all risk information and essential prescribing information which can be found in the AlloDerm® Regenerative Tissue Matrix, REVOLVE™ System, SPY Elite® Intraoperative Perfusion Assessment System, and Strattice™ Reconstructive Tissue Matrix Instructions for Use.